Company Filing History:
Years Active: 2009-2010
Title: Henricus Petrus Martinus Maria Van Assouw: Innovator in Cardiovascular Safety
Introduction
Henricus Petrus Martinus Maria Van Assouw is a notable inventor based in Oirschot, Netherlands. He has made significant contributions to the field of pharmacology, particularly in the area of cardiovascular safety. With a total of 2 patents to his name, Van Assouw's work focuses on the development of assays and kits that enhance the safety of new therapeutics.
Latest Patents
Van Assouw's latest patents include a groundbreaking invention titled "Cardiovascular safety assay." This invention provides assays and kits for screening test compounds for their capability to induce cardiotoxicity in a subject. The assays are based on the interaction of astemizole with the HERG potassium channel, which can predict the cardiotoxicity of compounds during the development of new therapeutics. Another significant patent is "Radiolabeled astemizole and method of making," which details a process for preparing a radiolabeled astemizole of a specific formula.
Career Highlights
Henricus Van Assouw is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to contribute to the development of safer therapeutic agents, thereby impacting patient care positively.
Collaborations
Throughout his career, Van Assouw has collaborated with esteemed colleagues, including Godelieve Irma Christine Maria Heylen and Cornelus Gerardus Maria Janssen. These collaborations have further enriched his research and innovations in the field.
Conclusion
Henricus Petrus Martinus Maria Van Assouw stands out as an influential inventor in the realm of cardiovascular safety. His patents reflect a commitment to improving the safety of new therapeutics, showcasing his dedication to advancing medical science.